Libya vs Saint Martin (French Part): Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Libya
0.2%
in 2024
Saint Martin (French Part)
0.2%
in 2024
Libya rank
98th
Saint Martin (French Part) rank
98th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Libya
- Saint Martin (French Part)
How they compare
Libya currently reports 0.2% against 0.2% in Saint Martin (French Part), a difference of 0.0%.
Across all 10 years both countries report, Saint Martin (French Part) has been ahead every year.
Libya ranks 98th and Saint Martin (French Part) ranks 98th of 246 countries.
Saint Martin (French Part) has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Libya | Saint Martin (French Part) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.2% | 0.3% | 0.1% | Saint Martin (French Part) |
| 2020s | 0.2% | 0.2% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Libya or Saint Martin (French Part)?
- Libya, at 0.2% against 0.2% in Saint Martin (French Part) as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Libya and Saint Martin (French Part)?
- 0.0%, with Libya ahead.
- How many years of comparable data are there for Libya and Saint Martin (French Part)?
- 10 years are reported by both, from 2015 to 2024.
- How do Libya and Saint Martin (French Part) rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Libya ranks 98th and Saint Martin (French Part) ranks 98th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.